Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Research_Institute
|
| gptkbp:acquisition |
Acquired_by_Labcorp_in_2015
|
| gptkbp:employees |
Over 15,000
|
| gptkbp:focusArea |
Biostatistics
Biotechnology Gastroenterology Immunology Oncology Transplantation Urology Neurology Ophthalmology Infectious Diseases Patient Recruitment Pediatrics Quality Assurance Endocrinology Hematology Dermatology Pharmaceutical Development Rare Diseases Cardiovascular Respiratory Regulatory Submissions Metabolic Disorders Pharmacovigilance Women’s Health Clinical Operations Clinical Pharmacology Real World Evidence Regulatory Consulting Diagnostics Development Data_Science Market_Access_Services Patient-Centric_Solutions Medical_Device_Development Toxicology_Services Clinical_Development_Services Integrated_Drug_Development Therapeutic_Expertise Bioanalytical_Services Laboratory_Animal_Services |
| gptkbp:founded |
1997
|
| gptkbp:globalPresence |
More than 60 countries
|
| gptkbp:headquarters |
gptkb:Princeton,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Covance Drug Development
|
| gptkbp:parentCompany |
gptkb:Labcorp
|
| gptkbp:services |
Regulatory Affairs
Clinical_Trial_Management Data_Management Laboratory_Services Preclinical_Services |
| gptkbp:website |
www.covance.com
|